Opsens Inc.

OpSens focuses mainly on physiological measurements, such as FFR and dPR in interventional cardiology. OpSens offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry…More and excellent lesions access. The OptoWire has been used in the diagnosis and treatment of over 90,000 patients in more than 30 countries. It is approved for sale in the United States, European Union, Japan, and Canada.